Publications

2020 cardiometabolic

Clinical Evaluation of Basal-Bolus Therapy Delivered by the V-Go ® Wearable Insulin Delivery Device in Patients with Type 2 Diabetes: A Retrospective Analysis

Pharmacy (Basel).

2020; 8(4): 215

2020 cardiometabolic

Effectiveness of V-Go® for Patients with Type 2 Diabetes in a Real-World Setting: A Prospective Observational Study

Drugs Real World Outcomes

2020; 7: 31-40

2020 cardiometabolic

Comprehensive Pulmonary Safety Review of Inhaled Technosphere^® Insulin in Patients with Diabetes Mellitus.

Clin. Drug Investigation.

2020; 40: 973–983

2020 cardiometabolic

Hypoglycaemia is reduced with use of inhaled Technosphere^® Insulin relative to insulin aspart in type 1 diabetes mellitus.

Diabet. Med.

2020; 37: 752–759

2020 cardiometabolic

Multicenter Real-World Assessment of the Effectiveness of V-Go Wearable Insulin Delivery Device in Adult Patients with Type 2 Diabetes (ENABLE Study): A Retrospective Analysis

Med Devices (Auckl).

2020; 13: 283-91

2019 cardiometabolic

A Pragmatic Clinical Trial to Compare the Real-World Effectiveness of V-Go versus Standard Delivery of Insulin in Patients with Advanced Type 2 Diabetes

J Health Econ Outcomes Res.

2019; 6(2): 70-83

2019 cardiometabolic

Effect of V-Go Versus Multiple Daily Injections on Glycemic Control, Insulin Use, and Diabetes Medication Costs Among Individuals with Type 2 Diabetes Mellitus

J Manag Care Spec Pharm.

2019; 25(10): 1111-23

2019 cardiometabolic

Clinical and economic considerations based on persistency with a novel insulin delivery device versus conventional insulin delivery in patients with type 2 diabetes: A retrospective analysis

Res Social Adm Pharm.

2019; 15(9): 1126-32

2019 orphan lung

Clofazimine inhalation suspension for the aerosol treatment of pulmonary nontuberculous mycobacterial infections

Journal of Cystic Fibrosis

2019; 5(18): 714-720

2018 cardiometabolic

Clinical Benefits Over Time Associated with Use of V-Go Wearable Insulin Delivery Device in Adult Patients with Diabetes: A Retrospective Analysis

Adv Ther.

2018; 35: 631-43

2018 cardiometabolic

Subcutaneous furosemide in heart failure: pharmacokinetic characteristics of a newly buffered solution.

JACC BASIC TRANSLATIONAL SCIENCE

2018; 3(1): 25-34.

2018 cardiometabolic

Improved Postprandial Glucose with Inhaled Technosphere Insulin Compared with Insulin Aspart in Patients with Type 1 Diabetes on Multiple Daily Injections: The STAT Study.

Diabetes Technol

2018; 20(10): 639-647